Explorable study - possible explanation for the reduced risk of urethral recurrence after Hautmann neobladder for bladder cancer.

Explorable study - possible explanation for the reduced risk of urethral recurrence after Hautmann neobladder for bladder cancer. - urethral recurrence after Hautmann neobladder

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31928

Enrollment

Registered

2008-08-21

Start date

2008-04-15

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tumor in urethra urethral tumor

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: group 1: - patients who underwent a cystectomy + Hautmann neobladder for bladder cancer - since at least 1 year ago - patients must be over 18 years of age;group 2: - patiënts who are plannend for TURP, bladder neck incision or urethrotomy (no malignancy). - patients must be over 18 years of age

Exclusion criteria

Exclusion criteria: group 1: - patients who underwent cystectomy with a type of urinary diversion other than Hautmann neobladder. - use of anticoagulant drugs;group 2: - history of urological malignancy - use of anticoagulant drugs

Design outcomes

Primary

Measure	Time frame
the immunostatus of the urethra.	—

Countries

Netherlands

Outcome results